Lorlatinib

ATC L01ED05 · 9 markets · 22 records

Lorlatinib 9 markets · 22 records Forms

AU 7 records · 3 strengths

  • 25 mgtabletLorviqua 25mg tabletsLORVIQUA lorlatinib 100 mg tablet bottle、LORVIQUA lorlatinib 25 mg tablet blister pack also in US·GB·CA +3 unknown
  • 100 mgtabletLorviqua 25mg tabletsLORVIQUA lorlatinib 100 mg tablet bottle、LORVIQUA lorlatinib 25 mg tablet blister pack also in US·GB·CA +2 unknown

Records without a stated strength · 1 Lorviqua 25mg tablets

US 3 records · 2 strengths

GB 2 records · 2 strengths

CA 2 records · 2 strengths

SG 2 records · 2 strengths

ES 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 Lorviqua 25mg tablets

    TW 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Lorviqua 25mg tablets

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.